Literature DB >> 35181754

Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study.

Chihiro Murayama1, Toshiki Iwabuchi2,3, Yasuhiko Kato1, Masamichi Yokokura1,2, Taeko Harada2,3, Takafumi Goto1, Taishi Tamayama1, Yosuke Kameno1, Tomoyasu Wakuda1, Hitoshi Kuwabara1,2, Atsushi Senju2,3,4, Sadahiko Nishizawa5, Yasuomi Ouchi6,7, Hidenori Yamasue8,9.   

Abstract

The social motivation hypothesis of autism proposes that social communication symptoms in autism-spectrum disorder (ASD) stem from atypical social attention and reward networks, where dopamine acts as a crucial mediator. However, despite evidence indicating that individuals with ASD show atypical activation in extrastriatal regions while processing reward and social stimuli, no previous studies have measured extrastriatal dopamine D2/3 receptor (D2/3R) availability in ASD. Here, we investigated extrastriatal D2/3R availability in individuals with ASD and its association with ASD social communication symptoms using positron emission tomography (PET). Moreover, we employed a whole-brain multivariate pattern analysis of resting-state functional magnetic resonance imaging (fMRI) to identify regions where functional connectivity atypically correlates with D2/3R availability depending on ASD diagnosis. Twenty-two psychotropic-free males with ASD and 24 age- and intelligence quotient-matched typically developing males underwent [11C]FLB457 PET, fMRI, and clinical symptom assessment. Participants with ASD showed lower D2/3R availability throughout the D2/3R-rich extrastriatal regions of the dopaminergic pathways. Among these, the posterior region of the thalamus, which primarily comprises the pulvinar, displayed the largest effect size for the lower D2/3R availability, which correlated with a higher score on the Social Affect domain of the Autism Diagnostic Observation Schedule-2 in participants with ASD. Moreover, lower D2/3R availability was correlated with lower functional connectivity of the thalamus-superior temporal sulcus and cerebellum-medial occipital cortex, specifically in individuals with ASD. The current findings provide novel molecular evidence for the social motivation theory of autism and offer a novel therapeutic target.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35181754     DOI: 10.1038/s41380-022-01464-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  60 in total

Review 1.  The social motivation theory of autism.

Authors:  Coralie Chevallier; Gregor Kohls; Vanessa Troiani; Edward S Brodkin; Robert T Schultz
Journal:  Trends Cogn Sci       Date:  2012-03-17       Impact factor: 20.229

2.  fMRI evidence of neural abnormalities in the subcortical face processing system in ASD.

Authors:  Natalia M Kleinhans; Todd Richards; L Clark Johnson; Kurt E Weaver; Jessica Greenson; Geraldine Dawson; Elizabeth Aylward
Journal:  Neuroimage       Date:  2010-07-23       Impact factor: 6.556

3.  D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

Authors:  J Thompson; N Thomas; A Singleton; M Piggott; S Lloyd; E K Perry; C M Morris; R H Perry; I N Ferrier; J A Court
Journal:  Pharmacogenetics       Date:  1997-12

4.  Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.

Authors:  Kazuhiko Nakamura; Yoshimoto Sekine; Yasuomi Ouchi; Masatsugu Tsujii; Etsuji Yoshikawa; Masami Futatsubashi; Kenji J Tsuchiya; Genichi Sugihara; Yasuhide Iwata; Katsuaki Suzuki; Hideo Matsuzaki; Shiro Suda; Toshiro Sugiyama; Nori Takei; Norio Mori
Journal:  Arch Gen Psychiatry       Date:  2010-01

5.  Evaluation of the Social Motivation Hypothesis of Autism: A Systematic Review and Meta-analysis.

Authors:  Caitlin C Clements; Alisa R Zoltowski; Lisa D Yankowitz; Benjamin E Yerys; Robert T Schultz; John D Herrington
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

6.  Gating of social reward by oxytocin in the ventral tegmental area.

Authors:  Lin W Hung; Sophie Neuner; Jai S Polepalli; Kevin T Beier; Matthew Wright; Jessica J Walsh; Eastman M Lewis; Liqun Luo; Karl Deisseroth; Gül Dölen; Robert C Malenka
Journal:  Science       Date:  2017-09-28       Impact factor: 47.728

7.  Look me in the eyes: constraining gaze in the eye-region provokes abnormally high subcortical activation in autism.

Authors:  Nouchine Hadjikhani; Jakob Åsberg Johnels; Nicole R Zürcher; Amandine Lassalle; Quentin Guillon; Loyse Hippolyte; Eva Billstedt; Noreen Ward; Eric Lemonnier; Christopher Gillberg
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

8.  Dopamine-dependent visual attention preference to social stimuli in nonhuman primates.

Authors:  Yoshie Yamaguchi; Takeshi Atsumi; Romain Poirot; Young-A Lee; Akemi Kato; Yukiori Goto
Journal:  Psychopharmacology (Berl)       Date:  2017-02-02       Impact factor: 4.530

9.  A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism.

Authors:  Nicole R Zürcher; Erin C Walsh; Rachel D Phillips; Paul M Cernasov; Chieh-En J Tseng; Ayarah Dharanikota; Eric Smith; Zibo Li; Jessica L Kinard; Joshua C Bizzell; Rachel K Greene; Daniel Dillon; Diego A Pizzagalli; David Izquierdo-Garcia; Kinh Truong; David Lalush; Jacob M Hooker; Gabriel S Dichter
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

10.  Binding of Dopamine D1 Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study.

Authors:  Manabu Kubota; Junya Fujino; Shisei Tei; Keisuke Takahata; Kiwamu Matsuoka; Kenji Tagai; Yasunori Sano; Yasuharu Yamamoto; Hitoshi Shimada; Yuhei Takado; Chie Seki; Takashi Itahashi; Yuta Y Aoki; Haruhisa Ohta; Ryu-Ichiro Hashimoto; Ming-Rong Zhang; Tetsuya Suhara; Motoaki Nakamura; Hidehiko Takahashi; Nobumasa Kato; Makoto Higuchi
Journal:  Cereb Cortex       Date:  2020-11-03       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.